Cochlear Limited yakawana mvumo yeU.S. Chikafu neDrug Administration (FDA) yeCochlear™ Nucleus® Implants yekurapa unilateral kunzwa kurasikirwa (UHL)/single-sided matsi (SSD). Iwo ma implant atove FDA akatenderwa kune avo vane mwero kusvika kune yakadzika bilateral sensorineural kunzwa kurasikirwa. Nemvumo iyi, kekutanga Cochlear inogona kuwedzera nzira dzekurapa dzinoisirwa kune avo vane UHL/SSD kuti ibatanidze cochlear implants.

UHL inorondedzerwa sekurasika kwekunzwa munzeve imwe uye pedyo nekunzwa kwepedyo-kwenguva dzose munzeve yakatarisana, uye SSD yakananga kune vanhu vane zvakanyanya kusvika pakurasikirwa kwekunzwa munzeve imwe uye yakajairika kana pedyo-yakajairika mune imwe nzeve. Gore rega rega, vanhu vanosvika zviuru makumi matanhatu muUnited States vanowana SSD.60,000

"Hazviwanzoiti kuti mvumo yekuwedzera zviratidzo uye kuwedzera ruzivo pamusoro pemishonga inoshanda yekurasikirwa nekunzwa inouya. Iye zvino nemvumo iyi, Cochlear inodada nekupa nzira dzekunzwa dzakanyanya kuwanikwa kune avo vane unilateral kurasikirwa kwekunzwa / kudivi rimwe-side matsi kuburikidza neyedu cochlear implant uye bone conduction mhinduro, "akadaro Christine Menapace, MA, Mutevedzeri weMutungamiri, Clinical Affairs, Cochlear. Americas. “Zvakakosha kuti avo vane rudzi urwu rwekurasikirwa nekunzwa vazive kukanganisa kwehupenyu hwavo uye vanzwisise kuti pane zvakawanda zvingasarudzwa kwavari, uye tinovakurudzira kuti vataure nenyanzvi yehutano hwekunzwa nhasi kuti vazive zvingavaitira zvakanaka. ”

UHL/SSD inogona kukanganisa mararamiro emunhu, kusanganisira kuneta kwepfungwa nekuda kwekuwedzera kwekuteerera, pamwe chete nemigumisiro yekunzwisisa kutaura muruzha uye kunogara munzvimbo inonzwika kubva.2-6 Kunzwa nenzeve mbiri kunokosha. Kunzwa nenzeve mbiri kunobatsira munhu kuziva manzwi ari pedyo nekure, pamwe chete neayo anoitika madhigirii 360 kutenderedza musoro.7

"Unilateral sensorineural kunzwa kurasikirwa kwakaramba kuchiwana kugamuchirwa kwakanyanya mumunda sechiratidzo chekudyara kwecochlear," akadaro Dr. Kevin Brown, Mutevedzeri weSachigaro, Mukuru weNeurotology uye Mutungamiri Mukuru weVana Cochlear Implant Center paYunivhesiti yeNorth Carolina. "Nemvumo iyi, zvakakosha kuti vandinoshanda navo muindasitiri uye ini ndive nechokwadi chekutungamira kwakakodzera kwekiriniki pamusoro penzira yekusuma iyi cochlear implant chiratidzo, tsanangura muenzaniso wekusarudza varwere vanozobatsira, uye nekuona kubudirira mushure mekudyarwa."

Cochlear ikozvino inotsigira avo vane UHL/SSD nekupa iyo cochlear implant, iyo Cochlear Nucleus System, uye bone conduction mhinduro, iyo Cochlear Osia® System uye iyo Cochlear Baha® System. Cochlear's inodyarwa yekunzwa mhinduro inodzoreredza kuwana kune ruzha kuvandudza hupenyu uye kusangana nemararamiro anodiwa uye zvaanoda zvega ega anogamuchira.

ZVOKUBVA MUNYAYA INO:

UHL is classified as hearing loss in one ear and near to near-normal hearing in the opposite ear, and SSD is specific to individuals with severe to profound hearing loss in one ear and normal or near-normal hearing in the other ear.
“It is important that those with this type of hearing loss recognize the impact to their lives and understand there are several options available to them, and we encourage them to talk to their hearing health professional today to find out what would work best for them.
Now with this approval, Cochlear is proud to offer the most hearing implant options available to those with unilateral hearing loss/single-sided deafness through our cochlear implant and bone conduction solutions,”.